ATLANTA — At the annual Conference on Retroviruses and Opportunistic Infections that took place almost exactly a year ago, researchers reported the first clinical evidence that the drug vorinostat could shock HIV out of its hiding places in patients, potentially allowing the once-dormant virus to be detected by the immune system and thereby ... (more)
http://www.nature.com/nm/journal/v19/n4/full/nm0413-384.html
http://www.nature.com/nm/journal/v19/n4/full/nm0413-384.html
No comments:
Post a Comment